Targeting mitotic exit with hyperthermia or APC/C inhibition to increase paclitaxel efficacy

S Giovinazzi, D Bellapu, VM Morozov, AM Ishov - Cell cycle, 2013 - Taylor & Francis
Microtubule-poisoning drugs, such as Paclitaxel (or Taxol, PTX), are powerful and
commonly used anti-neoplastic agents for the treatment of several malignancies. PTX …

Mechanism of G1-like arrest by low concentrations of paclitaxel: next cell cycle p53-dependent arrest with sub G1 DNA content mediated by prolonged mitosis

ZN Demidenko, S Kalurupalle, C Hanko, CU Lim… - Oncogene, 2008 - nature.com
Paclitaxel (PTX) and other microtubule inhibitors cause mitotic arrest. However, low
concentrations of PTX (low PTX) paradoxically cause G1 arrest (without mitotic arrest). Here …

Cellular effects of CPT‐11 on colon carcinoma cells: dependence on p53 and hMLH1 status

R Magrini, MR Bhonde, ML Hanski… - … journal of cancer, 2002 - Wiley Online Library
Abstract Irinotecan (CPT‐11), a recently introduced component of a standard chemotherapy
for colorectal cancer, induces in colon cancer cell lines in vitro cell cycle arrest and …

Apoptosis in 7-hydroxystaurosporine-treated T lymphoblasts correlates with activation of cyclin-dependent kinases 1 and 2.

Q Wang, PJ Worland, JL Clark, BA Carlson… - Cell Growth & …, 1995 - europepmc.org
7-Hydroxystaurosporine (UCN-01) is a potent inhibitor of protein kinase C (PKC) isozymes
alpha, beta, and gamma [Seynaeve et al., Mol. Pharmacol, 45: 1207-1214, 1994] that also …

Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway

CM Woods, J Zhu, PA McQueney, D Bollag… - Molecular …, 1995 - Springer
Background At therapeutic concentrations, the antineoplastic agent taxol selectively perturbs
mitotic spindle microtubules. Taxol has recently been shown to induce apoptosis, similar to …

PG490-88, a derivative of triptolide, causes tumor regression and sensitizes tumors to chemotherapy

JM Fidler, K Li, C Chung, K Wei, JA Ross, M Gao… - Molecular cancer …, 2003 - AACR
Abstract Treatment of solid tumors with combinations of chemotherapeutic agents has not
led to significant increases in long-term survival. Recent studies support a role for inhibitors …

UCN-01, 7-hydroxyl-staurosporine, inhibits kinase activity of cyclin-dependent kinases and reduces the phosphorylation of the retinoblastoma susceptibility gene …

K Kawakami, H Futami, J Takahara… - … and biophysical research …, 1996 - Elsevier
UCN-01 (7-hydroxyl-staurosporine), which was initially developed as a selective protein
kinase C inhibitor, has an anti-tumor effect on several human cancer cell linesin vivo. In this …

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

PR Graves, L Yu, JK Schwarz, J Gales… - Journal of Biological …, 2000 - ASBMB
A checkpoint operating in the G 2 phase of the cell cycle prevents entry into mitosis in the
presence of DNA damage. UCN-01, a protein kinase inhibitor currently undergoing clinical …

NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and mdulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and …

K Selvendiran, A Bratasz, L Tong, LJ Ignarro… - Cell Cycle, 2008 - Taylor & Francis
We have previously reported the inhibitory effect of NCX-4016, a nitro derivative of aspirin,
on the proliferation of cisplatin-resistant human ovarian cancer cells, in vitro (Bratasz et al …

Structural studies with inhibitors of the cell cycle regulatory kinase cyclin-dependent protein kinase 2

LN Johnson, E De Moliner, NR Brown, H Song… - Pharmacology & …, 2002 - Elsevier
Components of the cell cycle machinery are frequently altered in cancer. Many of these
alterations affect the cyclin-dependent kinases (CDKs) and their regulation. Staurosporine …